Report Details

According to the report published by the Market Research Store, global demand for the Acute Pancreatitis Treatment market was estimated at approximately USD 5,018.3 Million in 2020 and is anticipated to generate revenue of around USD 7,081.7 Million by end of 2026, growing at a CAGR of around 6.23% between 2021 and 2026.

Global Acute Pancreatitis Treatment Market: Overview

The term acute pancreatitis is a sudden inflammation in the pancreas due to numerous causes in the body together with gallstone, systemic disease, and use of heavy alcohol. Generally, gallstones produces about 40% of cases of acute pancreatitis. With the help of short-term hospitalization treatment, mild acute pancreatitis can be treated. In case of severe acute pancreatitis, patients need hospitalization for a longer period of time where they are likely to give intravenous fluids or admitted to the ICU for additional treatment.

REPORT SNAPSHOT & REPORTING DATA TIMEFRAME
Parameter Details
Historical Date ( Actual Data) 2016 - 2020
Base Year Data 2020
Current Year Data 2021
Projected Data 2021 - 2026
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered product type, application, region
Regional scope North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
Country Scope U.S.; Canada; Mexico; Germany; France; U.K.; China; Japan; South Korea; Singapore; Malaysia; Brazil; Saudi Arabia
Customization scope Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Acute Pancreatitis Treatment Market: Growth Factors

Due to the Increase in cases of obesity and gallstones the occurrence of acute pancreatitis patient is rising across the world. According to WHO, 39% of adults aged 18 years and above were overweight in 2016. Overall, about 13% of the world's adult population (15% of women and 11% of men) was obese in 2016. The incidence of obesity nearly tripled between 1975 and 2016 across the world. Prevalence of acute pancreatitis was reported from 17 countries across Europe and ranged from 4.6 to 100 per 100 000 population. Prevalence was usually elevated in eastern or northern Europe. Currently, acute pancreatitis is a highly common cause for hospitalization of a gastrointestinal related disease in the U.S. Presently, acute pancreatitis is a specifically usual cause for the hospitalization of a gastrointestinal related disease. Moreover, increasing awareness and advancements of essential devices and instruments is another factor stimulating the market growth. Also, increasing investment in healthcare sector will boost the market.

However, poor recovering policies for the treatment of this disorder may hinder the market growth.

Global Acute Pancreatitis Treatment Market: Segmentation

On the basis of type, the global acute pancreatitis treatment market is segmented into drug therapy, device based therapy and others. The drug-based therapy segment can be further divided into antibiotics, analgesics, and others and the device based therapy can be segmented into endoscopic retrograde cholangiopancreatography (ERCP), intravenous fluid, and surgery. The others segment can be segregated into antioxidant therapy, nutritional support, and others.

Further the market for acute pancreatitis treatment, the end user industry is classified into hospitals, antioxidant therapy and others.

Global Acute Pancreatitis Treatment Market: Regional Analysis

North America is dominating the acute pancreatitis treatment in terms of revenue followed by Europe. The reported yearly prevalence of acute pancreatitis in the U.S. ranges from 4.9 to 35 per 100,000 population. Moreover, the market in Asia Pacific is expected to grow at crucial CAGR during the forecast period. Furthermore, the increasing investment in healthcare sector in specific region enhances the market. In Japan, the approximated number of patients with AP showed a 1.8-fold growth in the last decade. In 2015, according to a survey published in NCBI, the incidences in Japan was 49.4 per 100,000 population.

Global Acute Pancreatitis Treatment Market: Competitive Players

Major key industries in global acute pancreatitis treatment market include, Samsung Bioepis, AstraZeneca, Pfizer, GNT Pharma, CalciMedica, B. Braun Melsungen, General Electric Company, Abbott Pharmaceutical, Fresenius Kabi USA, Sun BioPharma, GlaxoSmithKline, Novartis, Boston Scientific Corporation, SCM Lifescience, and Medtronic.

Global Acute Pancreatitis Treatment Market: By Type

  • Drug Therapy
  • Device Based Therapy
  •  Others

Global Acute Pancreatitis Treatment Market: By End User

  • Hospitals
  •  Antioxidant Therapy
  • Others

Global Acute Pancreatitis Treatment Market: Regional Segmentation Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

Frequently Asked Questions

What are the key factors driving global acute pancreatitis treatment market expansion?

Due to the Increase in cases of obesity and gallstones the occurrence of acute pancreatitis patient is rising across the world. Presently, acute pancreatitis is a specifically usual cause for the hospitalization of a gastrointestinal related disease. Moreover, increasing awareness and advancements of essential devices and instruments is another factor stimulating the market growth. Also, increasing investment in healthcare sector will boost the market.

What will be the value of global acute pancreatitis treatment market during 2020- 2026?

The acute pancreatitis treatment is expected to grow at a significant CAGR during the forecast period due to the essential products and the increase in investment of pharmaceutical companies.

Which region will make notable contributions towards global acute pancreatitis treatment market revenue?

North America is dominating the acute pancreatitis treatment in terms of revenue followed by Europe. Moreover, the market in Asia Pacific is expected to grow at crucial CAGR during the forecast period.

What are the key players leveraging global acute pancreatitis treatment market growth?

Major key industries in global acute pancreatitis treatment market include CalciMedica, SCM Lifescience, Samsung Bioepis, GNT Pharma Co, AstraZeneca, B. Braun Melsungen AG, General Electric Company, Medtronic, Abbott Laboratories, Sun BioPharma, Inc, Boston Scientific Corporation, Fresenius Kabi USA, GlaxoSmithKline, Novartis AG, and Pfizer.

Table Of Content

  • Chapter 1 Executive Summary
    • 1.1. Introduction of Acute Pancreatitis Treatment
    • 1.2. Global Acute Pancreatitis Treatment Market, 2020 & 2026 (USD Million)
    • 1.3. Global Acute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
    • 1.4. Global Acute Pancreatitis Treatment MarketAbsulute Revenue Opportunity, 2016 – 2026(USD Million)
    • 1.5. Global Acute Pancreatitis Treatment MarketIncremental Revenue Opportunity, 2020 – 2026(USD Million)
  • Chapter 2 Acute Pancreatitis Treatment Market – Type Analysis
    • 2.1. Global Acute Pancreatitis Treatment Market – Type Overview
    • 2.2. Global Acute Pancreatitis Treatment Market Share, by Type, 2020 & 2026(USD Million)
    • 2.3. Drug Therapy
      • 2.3.1. Global Drug TherapyAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
    • 2.4. Device Based Therapy
      • 2.4.1. Global Device Based TherapyAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
    • 2.5. Others
      • 2.5.1. Global OthersAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
  • Chapter 3 Acute Pancreatitis Treatment Market – End User Analysis
    • 3.1. Global Acute Pancreatitis Treatment Market – End User Overview
    • 3.2. Global Acute Pancreatitis Treatment Market Share, by End User, 2020 & 2026(USD Million)
    • 3.3. Hospitals
      • 3.3.1. Global HospitalsAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
    • 3.4. Antioxidant Therapy
      • 3.4.1. Global Antioxidant Therapy Acute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
    • 3.5. Others
      • 3.5.1. Global Others Acute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
  • Chapter 4 Acute Pancreatitis Treatment Market – Regional Analysis
    • 4.1. Global Acute Pancreatitis Treatment Market Regional Overview
    • 4.2. Global Acute Pancreatitis Treatment Market Share, by Region, 2020 & 2026(USD Million)
    • 4.3. North America
      • 4.3.1. North AmericaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
        • 4.3.1.1. North AmericaAcute Pancreatitis Treatment Market, by Country, 2016 - 2026(USD Million)
      • 4.3.2. North AmericaAcute Pancreatitis Treatment Market, by Type, 2016 – 2026
        • 4.3.2.1. North AmericaAcute Pancreatitis Treatment Market, by Type, 2016 – 2026(USD Million)
      • 4.3.3. North AmericaAcute Pancreatitis Treatment Market, by End User, 2016 – 2026
        • 4.3.3.1. North AmericaAcute Pancreatitis Treatment Market, by End User, 2016 – 2026(USD Million)
      • 4.3.4. U.S.
        • 4.3.4.1. U.S.Acute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.3.5. Canada
        • 4.3.5.1. CanadaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
    • 4.4. Europe
      • 4.4.1. EuropeAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
        • 4.4.1.1. EuropeAcute Pancreatitis Treatment Market, by Country, 2016 - 2026(USD Million)
      • 4.4.2. EuropeAcute Pancreatitis Treatment Market, by Type, 2016 – 2026
        • 4.4.2.1. EuropeAcute Pancreatitis Treatment Market, by Type, 2016 – 2026(USD Million)
      • 4.4.3. EuropeAcute Pancreatitis Treatment Market, by End User, 2016 – 2026
        • 4.4.3.1. EuropeAcute Pancreatitis Treatment Market, by End User, 2016 – 2026(USD Million)
      • 4.4.4. Germany
        • 4.4.4.1. GermanyAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.4.5. France
        • 4.4.5.1. FranceAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.4.6. U.K.
        • 4.4.6.1. U.K.Acute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.4.7. Italy
        • 4.4.7.1. ItalyAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.4.8. Spain
        • 4.4.8.1. SpainAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.4.9. Rest of Europe
        • 4.4.9.1. Rest of EuropeAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
    • 4.5. Asia Pacific
      • 4.5.1. Asia PacificAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
        • 4.5.1.1. Asia PacificAcute Pancreatitis Treatment Market, by Country, 2016 - 2026(USD Million)
      • 4.5.2. Asia PacificAcute Pancreatitis Treatment Market, by Type, 2016 – 2026
        • 4.5.2.1. Asia PacificAcute Pancreatitis Treatment Market, by Type, 2016 – 2026(USD Million)
      • 4.5.3. Asia PacificAcute Pancreatitis Treatment Market, by End User, 2016 – 2026
        • 4.5.3.1. Asia PacificAcute Pancreatitis Treatment Market, by End User, 2016 – 2026(USD Million)
      • 4.5.4. China
        • 4.5.4.1. ChinaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.5.5. Japan
        • 4.5.5.1. JapanAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.5.6. India
        • 4.5.6.1. IndiaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.5.7. South Korea
        • 4.5.7.1. South KoreaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.5.8. South-East Asia
        • 4.5.8.1. South-East AsiaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.5.9. Rest of Asia Pacific
        • 4.5.9.1. Rest of Asia PacificAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
    • 4.6. Latin America
      • 4.6.1. Latin AmericaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
        • 4.6.1.1. Latin AmericaAcute Pancreatitis Treatment Market, by Country, 2016 - 2026(USD Million)
      • 4.6.2. Latin AmericaAcute Pancreatitis Treatment Market, by Type, 2016 – 2026
        • 4.6.2.1. Latin AmericaAcute Pancreatitis Treatment Market, by Type, 2016 – 2026(USD Million)
      • 4.6.3. Latin AmericaAcute Pancreatitis Treatment Market, by End User, 2016 – 2026
        • 4.6.3.1. Latin AmericaAcute Pancreatitis Treatment Market, by End User, 2016 – 2026(USD Million)
      • 4.6.4. Brazil
        • 4.6.4.1. BrazilAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.6.5. Mexico
        • 4.6.5.1. MexicoAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.6.6. Rest of Latin America
        • 4.6.6.1. Rest of Latin AmericaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
    • 4.7. The Middle-East and Africa
      • 4.7.1. The Middle-East and AfricaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
        • 4.7.1.1. The Middle-East and AfricaAcute Pancreatitis Treatment Market, by Country, 2016 - 2026(USD Million)
      • 4.7.2. The Middle-East and AfricaAcute Pancreatitis Treatment Market, by Type, 2016 – 2026
        • 4.7.2.1. The Middle-East and AfricaAcute Pancreatitis Treatment Market, by Type, 2016 – 2026(USD Million)
      • 4.7.3. The Middle-East and AfricaAcute Pancreatitis Treatment Market, by End User, 2016 – 2026
        • 4.7.3.1. The Middle-East and AfricaAcute Pancreatitis Treatment Market, by End User, 2016 – 2026(USD Million)
      • 4.7.4. GCC Countries
        • 4.7.4.1. GCC CountriesAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.7.5. South Africa
        • 4.7.5.1. South AfricaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
      • 4.7.6. Rest of Middle-East Africa
        • 4.7.6.1. Rest of Middle-East AfricaAcute Pancreatitis Treatment Market, 2016 – 2026(USD Million)
  • Chapter 5 Acute Pancreatitis Treatment Market – Competitive Landscape
    • 5.1. Competitor Market Share – Revenue
    • 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    • 5.3. Strategic Developments
      • 5.3.1. Acquisitions and Mergers
      • 5.3.2. New Products
      • 5.3.3. Research & Development Activities
  • Chapter 6 Company Profiles
    • 6.1. CalciMedica
      • 6.1.1. Company Overview
      • 6.1.2. Product/ServicePortfulio
      • 6.1.3. CalciMedica Sales, Revenue, and Gross Margin
      • 6.1.4. CalciMedica Revenue and Growth Rate
      • 6.1.5. CalciMedica Market Share
      • 6.1.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.2. SCM Lifescience
      • 6.2.1. Company Overview
      • 6.2.2. Product/ServicePortfulio
      • 6.2.3. SCM Lifescience Sales, Revenue, and Gross Margin
      • 6.2.4. SCM Lifescience Revenue and Growth Rate
      • 6.2.5. SCM Lifescience Market Share
      • 6.2.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.3. Samsung Bioepis
      • 6.3.1. Company Overview
      • 6.3.2. Product/ServicePortfulio
      • 6.3.3. Samsung Bioepis Sales, Revenue, and Gross Margin
      • 6.3.4. Samsung Bioepis Revenue and Growth Rate
      • 6.3.5. Samsung Bioepis Market Share
      • 6.3.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.4. GNT Pharma Co
      • 6.4.1. Company Overview
      • 6.4.2. Product/ServicePortfulio
      • 6.4.3. GNT Pharma Co Sales, Revenue, and Gross Margin
      • 6.4.4. GNT Pharma Co Revenue and Growth Rate
      • 6.4.5. GNT Pharma Co Market Share
      • 6.4.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.5. AstraZeneca
      • 6.5.1. Company Overview
      • 6.5.2. Product/ServicePortfulio
      • 6.5.3. AstraZeneca Sales, Revenue, and Gross Margin
      • 6.5.4. AstraZeneca Revenue and Growth Rate
      • 6.5.5. AstraZeneca Market Share
      • 6.5.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
      • 6.6. B. Braun Melsungen AG
      • 6.6.1. Company Overview
      • 6.6.2. Product/ServicePortfulio
        • 6.6.3. B. Braun Melsungen AG Sales, Revenue, and Gross Margin
        • 6.6.4. B. Braun Melsungen AG Revenue and Growth Rate
        • 6.6.5. B. Braun Melsungen AG Market Share
      • 6.6.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.7. General Electric Company
      • 6.7.1. Company Overview
      • 6.7.2. Product/ServicePortfulio
      • 6.7.3. General Electric Company Sales, Revenue, and Gross Margin
      • 6.7.4. General Electric Company Revenue and Growth Rate
      • 6.7.5. General Electric Company Market Share
      • 6.7.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.8. Medtronic
      • 6.8.1. Company Overview
      • 6.8.2. Product/ServicePortfulio
      • 6.8.3. Medtronic Sales, Revenue, and Gross Margin
      • 6.8.4. Medtronic Revenue and Growth Rate
      • 6.8.5. Medtronic Market Share
      • 6.8.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.9. Abbott Laboratories
      • 6.9.1. Company Overview
      • 6.9.2. Product/ServicePortfulio
      • 6.9.3. Abbott Laboratories Sales, Revenue, and Gross Margin
      • 6.9.4. Abbott Laboratories Revenue and Growth Rate
      • 6.9.5. Abbott Laboratories Market Share
      • 6.9.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.10. Sun BioPharma, Inc
      • 6.10.1. Company Overview
      • 6.10.2. Product/ServicePortfulio
      • 6.10.3. Sun BioPharma, Inc Sales, Revenue, and Gross Margin
      • 6.10.4. Sun BioPharma, Inc Revenue and Growth Rate
      • 6.10.5. Sun BioPharma, Inc Market Share
      • 6.10.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.11. Boston Scientific Corporation
      • 6.11.1. Company Overview
      • 6.11.2. Product/ServicePortfulio
      • 6.11.3. Boston Scientific Corporation Sales, Revenue, and Gross Margin
      • 6.11.4. Boston Scientific Corporation Revenue and Growth Rate
      • 6.11.5. Boston Scientific Corporation Market Share
      • 6.11.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.12. Fresenius Kabi USA
      • 6.12.1. Company Overview
      • 6.12.2. Product/ServicePortfulio
      • 6.12.3. Fresenius Kabi USA Sales, Revenue, and Gross Margin
      • 6.12.4. Fresenius Kabi USA Revenue and Growth Rate
      • 6.12.5. Fresenius Kabi USA Market Share
      • 6.12.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.13. GlaxoSmithKline
      • 6.13.1. Company Overview
      • 6.13.2. Product/ServicePortfulio
      • 6.13.3. GlaxoSmithKline Sales, Revenue, and Gross Margin
      • 6.13.4. GlaxoSmithKline Revenue and Growth Rate
      • 6.13.5. GlaxoSmithKline Market Share
      • 6.13.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.14. Novartis AG
      • 6.14.1. Company Overview
      • 6.14.2. Product/ServicePortfulio
      • 6.14.3. Novartis AG Sales, Revenue, and Gross Margin
      • 6.14.4. Novartis AG Revenue and Growth Rate
      • 6.14.5. Novartis AG Market Share
      • 6.14.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.15. Pfizer
      • 6.15.1. Company Overview
      • 6.15.2. Product/ServicePortfulio
      • 6.15.3. Pfizer Sales, Revenue, and Gross Margin
      • 6.15.4. Pfizer Revenue and Growth Rate
      • 6.15.5. Pfizer Market Share
      • 6.15.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
  • Chapter 7 Acute Pancreatitis Treatment — Industry Analysis
    • 7.1. Introduction and Taxonomy
    • 7.2. Acute Pancreatitis Treatment Market – Key Trends
      • 7.2.1. Market Drivers
      • 7.2.2. Market Restraints
      • 7.2.3. Market Opportunities
    • 7.3. Value Chain Analysis
    • 7.4. Key Mandates and Regulations
    • 7.5. Technulogy Roadmap and Timeline
    • 7.6. Acute Pancreatitis Treatment Market – Attractiveness Analysis
      • 7.6.1. By Type
      • 7.6.2. By End User
      • 7.6.3. By Region
  • Chapter 8 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    • 8.1. Acute Pancreatitis Treatment Industrial Chain Analysis
    • 8.2. Downstream Buyers
    • 8.3. Distributors/Traders List
  • Chapter 9 Marketing Strategy Analysis
    • 9.1. Marketing Channel
    • 9.2. Direct Marketing
    • 9.3. Indirect Marketing
    • 9.4. Marketing Channel Development Trends
    • 9.5. Economic/Pulitical Environmental Change
  • Chapter 10 Report Conclusion& Key Insights
    • 10.1. Key Insights from Primary Interviews & Surveys Respondents
    • 10.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  • Chapter 11 Research Approach & Methodulogy
    • 11.1. Report Description
    • 11.2. Research Scope
    • 11.3. Research Methodulogy
      • 11.3.1. Secondary Research
      • 11.3.2. Primary Research
      • 11.3.3. Statistical Models
        • 11.3.3.1. Company Share Analysis Model
        • 11.3.3.2. Revenue Based Modeling
      • 11.3.4. Research Limitations

Inquiry For Buying

Acute Pancreatitis Treatment

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Acute Pancreatitis Treatment

Please fill out the form. We will contact you within 24 hours:
All fields required...

×

Avail PDF Sample Report

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com